ACC: Colorectal Cancer Tied to Higher Risk for Cardiovascular Death
By Lori Solomon HealthDay Reporter
THURSDAY, March 27, 2025 -- Colorectal cancer (CRC) is tied to an increased risk for cardiovascular mortality, especially in individuals younger than 50 years, according to a study presented at the annual meeting of the American College of Cardiology, held from March 29 to 31 in Chicago.
Manahil Khan and Ahsan Ayaz, M.D., from Montefiore St. Luke's Cornwall Hospital in Newburgh, New York, quantified cardiovascular mortality in patients with CRC. The analysis included 631,699 patients identified from the Surveillance, Epidemiology, and End Results database (2000 to 2021).
The researchers found that in the overall population, there was a significant increase in cardiovascular mortality (standardized mortality ratio [SMR], 1.16) with the highest risk within two years of CRC diagnosis (SMR, 1.45). This short-term cardiovascular mortality risk was greatest among younger adults (younger than 50 years; SMR, 2.40), men (SMR, 1.55), and non-Hispanic Black patients (SMR, 1.74).
"Based on our findings, the two-year period after a colorectal cancer diagnosis is a critical period when patients need aggressive care to improve cardiovascular outcomes," Ayaz said in a statement. "For example, there should be an aggressive approach to control cardiovascular risk factors and comorbidities like diabetes and hypertension. There is also a need for coordination between oncology teams and primary care teams, because most of those risk factors are managed by primary care providers."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-03-28 06:00
Read more

- Depemokimab Applications Accepted for Review by the US FDA for Asthma with Type 2 Inflammation and for Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
- Bad Meetings Can Leave You With a Productivity 'Hangover'
- Steep Decline In Fertility Among U.S. Women Younger Than 30
- Sarepta Therapeutics Shares Safety Update on Elevidys
- Global Increases in Obesity Set to Continue in Children, Teens to 2050
- Organ Transplant Patient Dies After Contracting Rabies
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions